JP2020533399A5 - - Google Patents

Download PDF

Info

Publication number
JP2020533399A5
JP2020533399A5 JP2020515882A JP2020515882A JP2020533399A5 JP 2020533399 A5 JP2020533399 A5 JP 2020533399A5 JP 2020515882 A JP2020515882 A JP 2020515882A JP 2020515882 A JP2020515882 A JP 2020515882A JP 2020533399 A5 JP2020533399 A5 JP 2020533399A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
disease
cancer
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020515882A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020533399A (ja
JP7170341B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/050689 external-priority patent/WO2019055528A1/en
Publication of JP2020533399A publication Critical patent/JP2020533399A/ja
Publication of JP2020533399A5 publication Critical patent/JP2020533399A5/ja
Application granted granted Critical
Publication of JP7170341B2 publication Critical patent/JP7170341B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020515882A 2017-09-13 2018-09-12 新規低分子化合物 Active JP7170341B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762558323P 2017-09-13 2017-09-13
US62/558,323 2017-09-13
PCT/US2018/050689 WO2019055528A1 (en) 2017-09-13 2018-09-12 NEW COMPOUND WITH SMALL MOLECULES

Publications (3)

Publication Number Publication Date
JP2020533399A JP2020533399A (ja) 2020-11-19
JP2020533399A5 true JP2020533399A5 (https=) 2021-10-21
JP7170341B2 JP7170341B2 (ja) 2022-11-14

Family

ID=65723058

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020515882A Active JP7170341B2 (ja) 2017-09-13 2018-09-12 新規低分子化合物

Country Status (9)

Country Link
US (3) US11186550B2 (https=)
EP (1) EP3681874B1 (https=)
JP (1) JP7170341B2 (https=)
KR (1) KR102644045B1 (https=)
CN (1) CN111372921B (https=)
AU (1) AU2018331371C1 (https=)
CA (1) CA3075649A1 (https=)
IL (1) IL273242B2 (https=)
WO (1) WO2019055528A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3075649A1 (en) 2017-09-13 2019-03-21 Cerepeut, Inc. A novel small molecule compound
CA3131294A1 (en) * 2019-02-27 2020-09-03 Cerepeut, Inc. Quinazolinone compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7368434B2 (en) 2002-06-27 2008-05-06 The Endowment For Research In Human Biology, Inc. Compounds useful for the inhibition of ALDH
WO2005051974A2 (en) 2003-06-09 2005-06-09 The Regents Of The University Of California Novel molecules for regulating cell death
AU2006303037A1 (en) 2005-10-21 2007-04-26 Merz Pharma Gmbh & Co Kgaa Chromenones and their use as modulators of metabotropic glutamate receptors
US9492450B2 (en) * 2011-04-19 2016-11-15 University of Pittsburgh—of the Commonwealth System of Higher Education Inhibition of dynamin related protein 1 to promote cell death
US8759097B2 (en) * 2011-04-19 2014-06-24 University of Pittsburgh—of the Commonwealth System of Higher Eduction Inhibition of dynamin related protein 1 to promote cell death
JP2013142070A (ja) 2012-01-11 2013-07-22 Nihon Univ ミトコンドリア分裂阻害剤を用いたtrail抵抗性の克服
CN105008515A (zh) 2012-12-28 2015-10-28 小利兰·斯坦福大学托管委员会 用于治疗线粒体疾病和用于使细胞分化成神经元的组合物和方法
US9289448B2 (en) 2013-03-15 2016-03-22 Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for treating alzheimer's disease and other tauopathies
US9730935B2 (en) * 2013-12-13 2017-08-15 The Board Of Trustees Of The Leland Stanford Junior University Targeting a non-canonical notch signaling pathway for cancer treatment
GB201522232D0 (en) 2015-12-16 2016-01-27 Liverpool School Tropical Medicine Combination product
CA3075649A1 (en) 2017-09-13 2019-03-21 Cerepeut, Inc. A novel small molecule compound

Similar Documents

Publication Publication Date Title
JP2024071370A5 (https=)
JP2019507781A5 (https=)
JP2023126440A5 (https=)
JP2018518537A5 (https=)
JP2019524883A5 (https=)
JP2015520151A5 (https=)
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
JP2016501221A5 (https=)
PH12020551488A1 (en) Novel calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agents
EA201690322A1 (ru) Терапевтически активные соединения и способы их применения
JP2019525899A5 (https=)
JP2018534286A5 (https=)
JP2015193630A5 (https=)
RU2020121152A (ru) Твердые формы ингибитора калликреина плазмы и их соли
JP2014530818A5 (https=)
JP2020533399A5 (https=)
JP2018521121A5 (https=)
JP2016510326A5 (https=)
JOP20210329A1 (ar) مركبات بيرازول مزدوجة الاستبدال كمثبطات كيتو هيكسو كيناز
JP2019529460A5 (https=)
JP2015516419A5 (https=)
JP2018145180A5 (https=)
JP2019151627A5 (https=)
RU2020131402A (ru) 4-метилдигидропиримидиноновые соединения и их применение в фармацевтике
JPWO2022221227A5 (https=)